Cyrus Karkaria
Corporate Officer/Principal presso LUPIN LIMITED
Profilo
Cyrus Karkaria is currently the President-Biotechnology at Lupin Ltd.
He was previously the Vice President-BPS & Operations at CuraGen Corp.
Karkaria holds a doctorate degree from the University of Maryland, a graduate degree from the University of Mumbai, and a graduate degree from Harvard Medical School.
Posizioni attive di Cyrus Karkaria
| Società | Posizione | Inizio |
|---|---|---|
| LUPIN LIMITED | Corporate Officer/Principal | 07/10/2011 |
Precedenti posizioni note di Cyrus Karkaria
| Società | Posizione | Fine |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Formazione di Cyrus Karkaria
| University of Maryland | Doctorate Degree |
| University of Mumbai | Graduate Degree |
| Harvard Medical School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LUPIN LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
- Borsa valori
- Insiders
- Cyrus Karkaria
